Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study

Patients with inflammatory bowel disease (IBD) present a higher risk of developing cardiovascular diseases (CVDs) due to chronic inflammation, which plays an essential role in atherogenesis. Hyperlipidemia is another risk factor for CVDs; however, the association between IBD, IBD medications, and hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tien, Ni, Wu, Tien-Yuan, Lin, Cheng-Li, Wu, Chia-Jui, Hsu, Chung-Y, Fang, Yi-Jen, Lim, Yun-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234280/
https://www.ncbi.nlm.nih.gov/pubmed/35770006
http://dx.doi.org/10.3389/fmed.2022.910623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234280/
https://www.ncbi.nlm.nih.gov/pubmed/35770006
http://dx.doi.org/10.3389/fmed.2022.910623

Ejemplares similares